Cargando…
Bortezomib Induced Hepatitis B Reactivation
Background. It has recently been reported that hepatitis B (HBV) reactivation often occurs after the use of rituximab and stem cell transplantation in patients with lymphoma who are hepatitis B surface antigen (HBsAg) negative. However, clinical data on HBV reactivation in multiple myeloma (MM) is l...
Autores principales: | Hussain, Salwa, Jhaj, Ruby, Ahsan, Samira, Ahsan, Muhammad, Bloom, Robert E., Jafri, Syed-Mohammed R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021848/ https://www.ncbi.nlm.nih.gov/pubmed/24876846 http://dx.doi.org/10.1155/2014/964082 |
Ejemplares similares
-
Response of Bortezomib Chemotherapy in Hepatic Amyloidosis
por: Hasan, Syed M., et al.
Publicado: (2018) -
A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma
por: Kim, Youngwoon, et al.
Publicado: (2012) -
Bicalutamide-induced hepatotoxicity: A rare adverse effect
por: Hussain, Salwa, et al.
Publicado: (2014) -
Fatality in Kikuchi-Fujimoto disease: A rare phenomenon
por: Barbat, Bianca, et al.
Publicado: (2017) -
Pituitary stalk interruption syndrome presenting as short stature: a case report
por: Ram, Nanik, et al.
Publicado: (2014)